Citation Impact
Citing Papers
CCR5-Reactive Antibodies in Seronegative Partners of HIV-Seropositive Individuals Down-Modulate Surface CCR5 In Vivo and Neutralize the Infectivity of R5 Strains of HIV-1 In Vitro
2000
HIV-Specific Cytotoxic T Lymphocytes, HLA-A11, and Chemokine-Related Factors May Act Synergistically to Determine HIV Resistance in CCR5 Δ32-Negative Female Sex Workers in Chiang Rai, Northern Thailand
2001
No Difference in in Vitro Susceptibility to HIV Type 1 between High-Risk HIV-Negative Ethiopian Commercial Sex Workers and Low-Risk Control Subjects
2001
HIV Type 1 Antigen-Responsive CD4 + T-Lymphocytes in Exposed Yet HIV Type 1 Seronegative Ugandans
2004
Production of a Novel Viral Suppressive Activity Associated with Resistance to Infection among Female Sex Workers Exposed to HIV Type 1
2001
HIV-Specific IgG in Cervicovaginal Secretions of Exposed HIV-Uninfected Female Sexual Partners of HIV-Infected Men
2001
IL-22 Participates in an Innate Anti-HIV-1 Host-Resistance Network through Acute-Phase Protein Induction
2007
Viral Double-Stranded RNA Triggers Ig Class Switching by Activating Upper Respiratory Mucosa B Cells through an Innate TLR3 Pathway Involving BAFF
2008
Infectious Human Immunodeficiency Virus Can Rapidly Penetrate a Tight Human Epithelial Barrier by Transcytosis in a Process Impaired by Mucosal Immunoglobulins
1999
The regulation of IgA class switching
2008
Influence of low FODMAP and gluten-free diets on disease activity and intestinal microbiota in patients with non-celiac gluten sensitivity
2018
Viral Load and Heterosexual Transmission of Human Immunodeficiency Virus Type 1
2000 Standout
Factors Contributing to the Lack of Human Immunodeficiency Virus Type 1 (HIV‐1) Transmission in HIV‐1–Discordant Partners
2000
The CD85j+ NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
2008 StandoutNobel
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
2000 Standout
Protection against Human Immunodeficiency Virus Type 1 Infection in Persons with Repeated Exposure: Evidence for T Cell Immunity in the Absence of Inherited CCR5 Coreceptor Defects
1999
Cervicovaginal Secretory Antibodies to Human Immunodeficiency Virus Type 1 (HIV‐1) that Block Viral Transcytosis through Tight Epithelial Barriers in Highly Exposed HIV‐1–Seronegative African Women
2001
Neutralization of Human Immunodeficiency Virus Type 1 (HIV‐1) Mediated by Parotid IgA of HIV‐1–Infected Patients
2000
Homozygous and Heterozygous CCR5-Δ32 Genotypes Are Associated With Resistance to HIV Infection
2001
Human α Defensin in HIV-Exposed But Uninfected Individuals
2004
Influence of HLA Supertypes on Susceptibility and Resistance to Human Immunodeficiency Virus Type 1 Infection
2000
Correlates of Nontransmission in US Women at High Risk of Human Immunodeficiency Virus Type 1 Infection through Sexual Exposure
2002
Primer3—new capabilities and interfaces
2012 Standout
Human Immunodeficiency Virus (HIV)–Specific Cytotoxic T Lymphocyte Activity in HIV‐Exposed Seronegative Persons
1999
Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial
1999 Standout
HIV Type 1 Resistance in Kenyan Sex Workers Is Not Associated with Altered Cellular Susceptibility to HIV Type 1 Infection or Enhanced β-Chemokine Production
1998
Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis
1998
Current progress in the development of human immunodeficiency virus vaccines: research and clinical trials
2001
Genital Infection of Female Chimpanzees with Human Immunodeficiency Virus Type 1
1998 StandoutNobel
Single-nucleotide polymorphism (SNP) genotyping using cationic conjugated polymers in homogeneous solution
2009
MPprimer: a program for reliable multiplex PCR primer design
2010
Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.
1998
Mucosal immunity and vaccines
2005 Standout
Intracellular Neutralization of HIV Transcytosis across Tight Epithelial Barriers by Anti-HIV Envelope Protein dIgA or IgM
1998
Serum IgA of HIV-exposed uninfected individuals inhibit HIV through recognition of a region within the α-helix of gp41
2002
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model
2008 Standout
Prostate cancer and inflammation: the evidence
2011
Protective immunity induced by live attenuated simian immunodeficiency virus
1998
Mismatched Human Leukocyte Antigen Alleles Protect Against Heterosexual HIV Transmission
2001
HIV-specific CD8 T-cell activity in uninfected injection drug users is associated with maintenance of seronegativity
2002
HIV-Specific Antibodies But Not T-Cell Responses Are Associated With Protection in Seronegative Partners of HIV-1-Infected Individuals in Cambodia
2006 StandoutNobel
CD4 cell and CD8 cell-mediated resistance to HIV-1 infection in exposed uninfected intravascular drug users in Vietnam
2003 StandoutNobel
Brief but Efficient: Acute HIV Infection and the Sexual Transmission of HIV
2004
Pre-eclampsia
2005 Standout
Distinct patterns of HIV-specific memory T lymphocytes in HIV-exposed uninfected individuals and in HIV-infected patients
2005
Repertoire of Chemokine Receptor Expression in the Female Genital Tract
1998
Whole-genome sequencing of rifampicin-resistant Mycobacterium tuberculosis strains identifies compensatory mutations in RNA polymerase genes
2011
Broad Human Immunodeficiency Virus (HIV)–Specific T Cell Responses to Conserved HIV Proteins in HIV‐Seronegative Women Highly Exposed to a Single HIV‐Infected Partner
2003
Intestinal mucosal barrier function in health and disease
2009 Standout
Epidemiologic and Biologic Characterization of a Cohort of Human Immunodeficiency Virus Type 1 Highly Exposed, Persistently Seronegative Female Sex Workers in Northern Thailand
1999
Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis
2012
Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate
2000
Increased sensitivity of HIV-1 antibody detection
1997
HIV pathogenesis: mechanisms of susceptibility and disease progression
1998
The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation
2008 Standout
Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense
2011 StandoutNobel
Intestinal epithelial cells: regulators of barrier function and immune homeostasis
2014 Standout
Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers
2001
Cross-Clade HIV-1–Specific Neutralizing IgA in Mucosal and Systemic Compartments of HIV-1–Exposed, Persistently Seronegative Subjects
2002
Mucosal and systemic HIV-1-specific immunity in HIV-1-exposed but uninfected heterosexual men
2003
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
2008 Standout
New insights into HIV-1 specific cytotoxic T-lymphocyte responses in exposed, persistently seronegative Kenyan sex workers
2001
Anti-Cell Antibodies in Exposed Seronegative Individuals with HIV Type 1-Neutralizing Activity
2000
Reduced Cell Surface Expression of CCR5 in CCR5Δ32 Heterozygotes Is Mediated by Gene Dosage, Rather Than by Receptor Sequestration
2002 StandoutNobel
Mucosal vaccines: the promise and the challenge
2006
Preparation of Clinical‐Grade Recombinant Canarypox–Human Immunodeficiency Virus Vaccine–Loaded Human Dendritic Cells
2002 StandoutNobel
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
A systematic review of Leptospira in water and soil environments
2020 Standout
Increased IFN-γ production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals
2006
Urinary Tract Infection Syndromes
2013 Standout
Equivalent Immunogenicity of the Highly Attenuated Poxvirus-Based ALVAC-SIV and NYVAC-SIV Vaccine Candidates in SIVmac251-Infected Macaques
2002
HIV-1 Neutralization Profile and Plant-Based Recombinant Expression of Actinohivin, an Env Glycan-Specific Lectin Devoid of T-Cell Mitogenic Activity
2010 StandoutNobel
Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens
2008 Standout
NF-κB, inflammation, immunity and cancer: coming of age
2018 Standout
Gut microbiota in human metabolic health and disease
2020 Standout
The gut microbiota shapes intestinal immune responses during health and disease
2009 Standout
Real-time PCR in the microbiology laboratory
2004
Effect of heterosexual intercourse on mucosal alloimmunisation and resistance to HIV-1 infection
2004
Presence of Effector CD8+ T Cells in Hepatitis C Virus-Exposed Healthy Seronegative Donors
1999
Conserved CTL Epitopes Shared Between HIV-Infected Human Long-Term Survivors and Chimpanzees
1999
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
2011 StandoutNobel
Enhanced SARS-CoV-2 neutralization by dimeric IgA
2020 StandoutNobel
Study of the V3 Loop as a Target Epitope for Antibodies Involved in the Neutralization of Primary Isolates versus T-Cell-Line-Adapted Strains of Human Immunodeficiency Virus Type 1
1998
DEC-205 receptor on dendritic cells mediates presentation of HIV gag protein to CD8 + T cells in a spectrum of human MHC I haplotypes
2007 StandoutNobel
Potentiation of Simian Immunodeficiency Virus (SIV)-Specific CD4+ and CD8+ T Cell Responses by a DNA-SIV and NYVAC-SIV Prime/Boost Regimen
2001
Resistance to HIV-1 infection: lessons learned from studies of highly exposed persistently seronegative (HEPS) individuals.
2003
Increased Macrophage Infection upon Subcutaneous Inoculation of Rhesus Macaques with Simian Immunodeficiency Virus-Loaded Dendritic Cells or T Cells but Not with Cell-Free Virus
2002 StandoutNobel
Cell-to-Cell Contact Results in a Selective Translocation of Maternal Human Immunodeficiency Virus Type 1 Quasispecies across a Trophoblastic Barrier by both Transcytosis and Infection
2001 StandoutNobel
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
2009 Standout
Toward a live microbial microbicide for HIV: Commensal bacteria secreting an HIV fusion inhibitor peptide
2005
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Enhanced T-Cell Immunogenicity and Protective Efficacy of a Human Immunodeficiency Virus Type 1 Vaccine Regimen Consisting of Consecutive Priming with DNA and Boosting with Recombinant Fowlpox Virus
1998
Specific-Antibody-Secreting Cells in the Rectums and Genital Tracts of Nonhuman Primates following Vaccination
1998
Engineering microbial consortia: a new frontier in synthetic biology
2008 StandoutNobel
Atraumatic Oral Spray Immunization with Replication-Deficient Viral Vector Vaccines
2007 StandoutNobel
Mutational Pathways, Resistance Profile, and Side Effects of Cyanovirin Relative to Human Immunodeficiency Virus Type 1 Strains with N-Glycan Deletions in Their gp120 Envelopes
2006
Kinetics of CD4+and CD8+Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees
2003 StandoutNobel
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis
2017 StandoutNobel
CHEMOKINE RECEPTORS AS HIV-1 CORECEPTORS: Roles in Viral Entry, Tropism, and Disease
1999 Standout
Lack of infection in HIV-exposed individuals is associated with a strong CD8+cell noncytotoxic anti-HIV response
1999
Molecular and Immunological Significance of Chimpanzee Major Histocompatibility Complex Haplotypes for Hepatitis C Virus Immune Response and Vaccination Studies
2002 StandoutNobel
Mature Dendritic Cells Infected with Canarypox Virus Elicit Strong Anti-Human Immunodeficiency Virus CD8+and CD4+T-Cell Responses from Chronically Infected Individuals
2001 StandoutNobel
Water-Soluble Conjugated Polymers for Imaging, Diagnosis, and Therapy
2012 Standout
Most Highly Exposed Seronegative Men Lack HIV-1-Specific, IFN-γ-Secreting T Cells
2003
Immunoglobulin G (IgG) and IgA, but also Nonantibody Factors, Account for In Vitro Neutralization of Human Immunodeficiency Virus (HIV) Type 1 Primary Isolates by Serum and Plasma of HIV-Infected Patients
2001 StandoutNobel
Predictive value of anti-cell and anti-human immunodeficiency virus (HIV) humoral responses in HIV-1-exposed seronegative cohorts of European and Asian origin
2005
Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant,rpoBMutant Mycobacterium tuberculosis
2012 StandoutNobel
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug Users
2003 StandoutNobel
Mechanism by which the lectin actinohivin blocks HIV infection of target cells
2009 StandoutNobel
HIV VACCINES
2005
Human immunodeficiency virus‐1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus
2001
Endogenously Expressed nef Uncouples Cytokine and Chemokine Production from Membrane Phenotypic Maturation in Dendritic Cells
2002 StandoutNobel
Neutralizing Monoclonal Antibodies Block Human Immunodeficiency Virus Type 1 Infection of Dendritic Cells and Transmission to T Cells
1998 StandoutNobel
The Simian Immunodeficiency Virus ΔnefVaccine, after Application to the Tonsils of Rhesus Macaques, Replicates Primarily within CD4+T Cells and Elicits a Local Perforin-Positive CD8+T-Cell Response
2002 StandoutNobel
HIV-1-Specific Mucosal CD8+ Lymphocyte Responses in the Cervix of HIV-1-Resistant Prostitutes in Nairobi
2000
Works of Francesca Meacci being referenced
Characteristics of drug-resistant tuberculosis in Abkhazia (Georgia), a high-prevalence area in Eastern Europe
2009
The microbicide cyanovirin-N expressed on the surface of commensal bacterium Streptococcus gordonii captures HIV-1
2002
Diagnostic accuracy of anti-gliadin antibodies in Non-Celiac Gluten Sensitivity (NCGS) patients
2015
Treatment of Tuberculosis in a Region with High Drug Resistance: Outcomes, Drug Resistance Amplification and Re-Infection
2011
HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals
1997
Epidemiological features and resistance pattern in uropathogens isolated from chronic bacterial prostatitis
2011
The Role of Asymptomatic Bacteriuria in Young Women With Recurrent Urinary Tract Infections: To Treat or Not to Treat?
2012
Human Immunodeficiency Virus (HIV)–Specific IgA and HIV Neutralizing Activity in the Serum of Exposed Seronegative Partners of HIV‐Seropositive Persons
1999
Evaluation of Molecular-Beacon, TaqMan, and Fluorescence Resonance Energy Transfer Probes for Detection of Antibiotic Resistance-Conferring Single Nucleotide Polymorphisms in Mixed Mycobacterium tuberculosis DNA Extracts
2006
Molecular detection of Leptospira interrogans in human tissues and environmental samples in a lethal case of leptospirosis
2007
Protocol for Real-Time PCR Identification of Anthrax Spores from Nasal Swabs after Broth Enrichment
2002